Gryphon Financial Partners’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
CIA
CAI
SIC
KA
SSWG
CL
MCM
AF
Gryphon Financial Partners's IBDX Position: Q2 2026 in Review
Gryphon Financial Partners reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 7.9% in Q2 2026, selling an estimated $38.7K and leaving 17,775 shares worth $448K. The position accounts for 0.04% of the portfolio, ranked #247.
Gryphon Financial Partners first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $495K in Q2 2025. 136 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Gryphon Financial Partners held 17,775 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $448K as of Q2 2026.
- Gryphon Financial Partners sold 1,534 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $38.7K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.04% of Gryphon Financial Partners's portfolio in Q2 2026, its #247 holding.
- Gryphon Financial Partners first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
- Gryphon Financial Partners's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $495K in Q2 2025.
- 136 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.